LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Net Income (Loss) Attributable to Parent for the quarter ending August 25, 2024 was -$16.2M, a 50.9% decline year-over-year.
  • Lifecore Biomedical, Inc. \De\ Net Income (Loss) Attributable to Parent for the twelve months ending August 25, 2024 was $6.54M.
  • Lifecore Biomedical, Inc. \De\ annual Net Income (Loss) Attributable to Parent for 2023 was $12M.
  • Lifecore Biomedical, Inc. \De\ annual Net Income (Loss) Attributable to Parent for 2022 was -$99.6M, a 14.7% increase from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Net Income (Loss) Attributable to Parent for 2021 was -$117M, a 261% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.54M -$16.2M -$5.48M -50.9% May 27, 2024 Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $12M -$7.08M +$32.2M +82% Feb 26, 2024 May 26, 2024 10-K 2024-08-26
Q1 2024 -$20.2M $15.6M +$52.1M Nov 27, 2023 Feb 25, 2024 10-Q 2024-08-09
Q4 2023 -$72.3M $14.2M +$27M Aug 28, 2023 Nov 26, 2023 10-Q 2024-08-09
Q3 2023 -$99.4M -$10.8M +$212K +1.93% May 29, 2023 Aug 27, 2023 10-Q 2024-10-04
Q2 2023 -$99.6M -$39.3M +$16M +28.9% Feb 27, 2023 May 28, 2023 10-K 2024-08-26
Q1 2023 -$116M -$36.5M -$22.9M -169% Nov 28, 2022 Feb 26, 2023 10-Q 2024-08-09
Q4 2022 -$92.6M -$12.8M +$25.7M +66.7% Aug 29, 2022 Nov 27, 2022 10-Q 2024-08-09
Q3 2022 -$118M -$11M -$1.58M -16.8% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q2 2022 -$117M -$55.3M -$54M -4208% Feb 28, 2022 May 29, 2022 10-K 2024-08-26
Q1 2022 -$62.7M -$13.6M -$6.61M -94.7% Nov 29, 2021 Feb 27, 2022 10-K 2024-03-20
Q4 2021 -$56.1M -$38.5M -$26.8M -231% Aug 30, 2021 Nov 28, 2021 10-K 2024-03-20
Q3 2021 -$29.3M -$9.39M +$3.02M +24.4% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q2 2021 -$32.3M -$1.28M +$13.9M +91.5% Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 -$46.2M -$6.98M +$4.54M +39.4% Nov 30, 2020 Feb 28, 2021 10-K 2024-03-20
Q4 2020 -$50.7M -$11.6M -$4.88M -72.4% Aug 31, 2020 Nov 29, 2020 10-K 2024-03-20
Q3 2020 -$45.8M -$12.4M -$7.63M -159% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q2 2020 -$38.2M -$15.1M -$14.9M -5682% Feb 24, 2020 May 31, 2020 10-K 2021-07-29
Q1 2020 -$23.3M -$11.5M -$12.6M -1179% Nov 25, 2019 Feb 23, 2020 10-K 2021-07-29
Q4 2019 -$10.7M -$6.74M -$6.16M -1054% Aug 26, 2019 Nov 24, 2019 10-K 2021-07-29
Q3 2019 -$4.56M -$4.78M -$4.97M -2618% May 27, 2019 Aug 25, 2019 10-K 2021-07-29
Q2 2019 $411K -$262K -$6.37M -104% Feb 25, 2019 May 26, 2019 10-K 2020-08-14
Q1 2019 $6.78M $1.07M -$15M -93.4% Nov 26, 2018 Feb 24, 2019 10-K 2020-08-14
Q4 2018 $21.8M -$584K -$1.07M -220% Aug 27, 2018 Nov 25, 2018 10-K 2020-08-14
Q3 2018 $22.9M $190K -$1.96M -91.1% May 28, 2018 Aug 26, 2018 10-K 2020-08-14
Q2 2018 $24.8M $6.11M +$3.66M +149% Feb 26, 2018 May 27, 2018 10-K 2019-08-01
Q1 2018 $21.2M $16.1M +$12.6M +360% Nov 27, 2017 Feb 25, 2018 10-K 2019-08-01
Q4 2017 $8.59M $487K -$839K -63.3% Aug 28, 2017 Nov 26, 2017 10-K 2019-08-01
Q3 2017 $9.42M $2.15M -$1.17M -35.2% May 29, 2017 Aug 27, 2017 10-K 2019-08-01
Q2 2017 $10.6M $2.45M -$2.28M -48.2% Feb 27, 2017 May 28, 2017 10-K 2018-08-09
Q1 2017 $12.9M $3.5M +$24.7M Nov 28, 2016 Feb 26, 2017 10-K 2018-08-09
Q4 2016 -$11.8M $1.33M -$542K -29% Aug 29, 2016 Nov 27, 2016 10-K 2018-08-09
Q3 2016 -$11.3M $3.31M +$360K +12.2% May 30, 2016 Aug 28, 2016 10-K 2018-08-09
Q2 2016 -$11.6M $4.73M +$533K +12.7% Mar 1, 2016 May 29, 2016 10-K/A 2018-03-15
Q1 2016 -$12.2M -$21.2M -$25M -662% Nov 30, 2015 Feb 28, 2016 10-K/A 2018-03-15
Q4 2015 $12.8M $1.87M -$1.36M -42% Aug 31, 2015 Nov 29, 2015 10-K/A 2018-03-15
Q3 2015 $14.1M $2.95M +$599K +25.5% Jun 1, 2015 Aug 30, 2015 10-K/A 2018-03-15
Q2 2015 $13.5M $4.2M -$346K -7.62% Mar 2, 2015 May 31, 2015 10-K/A 2018-03-15
Q1 2015 $13.9M $3.77M -$2.63M -41.1% Dec 1, 2014 Mar 1, 2015 10-K/A 2018-03-15
Q4 2014 $16.5M $3.22M -$228K -6.61% Sep 1, 2014 Nov 30, 2014 10-K/A 2018-03-15
Q3 2014 $16.7M $2.35M -$2.4M -50.5% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $19.1M $4.54M +$23K +0.51% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $19.1M $6.4M +$1.61M +33.6% Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 $17.5M $3.45M -$5.46M -61.3% Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 $23M $4.75M +$386K +8.84% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q2 2013 $22.6M $4.52M +$1.74M +62.6% Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 $20.8M $4.79M +$24K +0.5% Nov 26, 2012 Feb 24, 2013 10-Q 2014-03-28
Q4 2012 $20.8M $8.91M +$5.57M +167% Aug 27, 2012 Nov 25, 2012 10-Q 2014-01-03
Q3 2012 $15.3M $4.37M +$2.55M +141% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q2 2012 $12.7M $2.78M +$5.52M Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 $7.18M $4.77M +$2.47M +107% Nov 28, 2011 Feb 26, 2012 10-Q 2013-04-04
Q4 2011 $4.71M $3.34M +$1.29M +62.5% Aug 29, 2011 Nov 27, 2011 10-Q 2013-01-04
Q3 2011 $3.43M $1.81M -$492K -21.4% May 28, 2011 Aug 28, 2011 10-Q/A 2013-01-02
Q2 2011 $3.92M -$2.74M Feb 28, 2011 May 29, 2011 10-K 2013-08-07
Q1 2011 $2.3M Nov 29, 2010 Feb 27, 2011 10-Q 2012-03-28
Q4 2010 $2.06M Aug 30, 2010 Nov 28, 2010 10-Q 2012-01-05
Q3 2010 $2.3M Jun 1, 2010 Aug 29, 2010 10-Q 2011-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.